Connect with us

Technology

8BitDo’s Pro 2 controller adds back paddles and a quick profile switcher – Yahoo Finance Australia

8BitDo has launched the 8BitDo Pro 2 as a follow-up to the SN30 Pro+ Bluetooth controller that came out in 2019, and it offers additional features for the…

Published

on

Article feature image

Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRP-Fc-CD40L), expected in the second half of 2021 Dose-escalation data from Phase 1 clinical trial for lead partnered PD-1 checkpoint inhibitor, SL-279252 (PD1-Fc-OX40L), expected in the second half of 2021 AUSTIN, TX and DURHAM, NC, March 15, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending